Drugs · acquisition-cost intelligence
AKIN ANTI-FUNGAL
Clotrimazole· ingredient clotrimazoleAntiinfectives and antiseptics for local oral treatment· CLOTRIMAZOLE 10 g/L; CLOTRIMAZOLE 10 mg/mL; CLOTRIMAZOLE 1 g/100mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.51121
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other clotrimazole products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Femmesil | $0.08864 | −$0.42260 |
| Antifungal | $0.13045 | −$0.38080 |
| clotrimazole | $0.28713 | −$0.22410 |
| CVS Pharmacy Clotrimazole 3 | $0.30100 | −$0.21020 |
Medicare Part D coverage · CY2026
On 264 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 54% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.